Coverage
-
July 01, 2019
TWi Pharmaceuticals must foot part of Supernus Pharmaceuticals' legal bills after relying on a position that was "squarely at odds with the evidence presented" at a patent infringement trial, a New Jersey federal judge has ruled.
1 other articles on this case.
View all »